<?xml version="1.0" encoding="UTF-8"?>
<p>The cardiovascular toxicity of 
 <italic>C. aurantium</italic> extracts with different concentrations of protoalkaloid 
 <italic>p</italic>-synephrine (4 and 6%) was reported by Calapai et al. in 1999 in rats. Authors showed an antiobesity effect by the administration of 
 <italic>C. aurantium</italic> but also possible cardiovascular toxicity. The cardiovascular effects have not been confirmed by studies using much higher doses of 
 <italic>p</italic>-synephrine [
 <xref rid="B65" ref-type="bibr">65</xref>].
</p>
